Literature DB >> 2851038

Adrenoceptor status and cardiovascular function in ageing.

K O'Malley1, J R Docherty, J G Kelly.   

Abstract

Adrenoceptor function is an important determinant of the physiological control of the circulation and of the response to drugs acting via the sympathetic nervous system and on the vasculature. There is little consistent evidence for an age-dependent change in alpha-adrenoceptor function though the response to various vasoconstrictor agents including alpha 1 agonists has been shown to change with ageing. These changes seem to reflect structural or functional factors and are not specific for receptor types. In the case of beta-adrenoceptor mediated responses there is evidence for both a decrease in response as well as age-related changes in the functioning of various components of the beta-adrenoceptor system, including receptor affinity, which is decreased. It may well be that decreased beta-adrenoceptor function with ageing contributes to altered cardiovascular control and to decreased efficacy of beta-adrenoceptor blocking drugs in elderly hypertensives.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2851038

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  4 in total

Review 1.  Clinical pharmacology, physiology and pathophysiology of superficial veins--2.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1994-10       Impact factor: 4.335

Review 2.  Hypertension in the elderly: epidemiology and pathophysiology.

Authors:  J J McNeil; C A Silagy
Journal:  Cardiovasc Drugs Ther       Date:  1991-01       Impact factor: 3.727

3.  The effects of age on human venous responsiveness to neuropeptide Y.

Authors:  M L Lambert; I D Callow; Q P Feng; J M Arnold
Journal:  Br J Clin Pharmacol       Date:  1999-01       Impact factor: 4.335

4.  Attenuation of autonomic nervous system functions in hypertensive patients at rest and during orthostatic stimulation.

Authors:  Maria Karas; Pierre Larochelle; Robert A LeBlanc; Bruno Dubé; Reginald Nadeau; Jacques de Champlain
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-02       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.